Food News and Research

RSS

Researchers discover 16 genes linked with breast cancer prognosis

Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.

26 Sep 2011

The Journal of Pain publishes results from Butrans Transdermal System Phase 3 clinical study

Butrans (Buprenorphine) Transdermal System CIII 20 mcg/hour provided significantly lower "average pain over the last 24 hours" scores compared to Butrans 5 mcg/hour when used in opioid-experienced patients with moderate-to-severe chronic low back pain, according to a pivotal Phase 3 clinical study published in the online, August issue of The Journal of Pain.

26 Sep 2011

RegeneRx completes RGN-259 Phase 2 trial on dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. today announced that treatment and follow-up have been completed on 69 patients in the Company's Phase 2 clinical trial with RGN-259 for the treatment of dry eye syndrome, five more than the number of evaluable patients contemplated in the trial's protocol.

26 Sep 2011

Janssen Biotech receives FDA approval for Remicade to treat UC in children

The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

26 Sep 2011

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

The U.S. Food and Drug Administration today approved Soliris (eculizumab) to treat patients with atypical Hemolytic Uremic Syndrome (aHUS), a rare and chronic blood disease that can lead to kidney (renal) failure and is also associated with increased risk of death and stroke.

26 Sep 2011

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.

23 Sep 2011

Gender discrimination a driving factor behind malnutrition in Nepal, experts say

"Gender discrimination lies behind much of the malnutrition found in under-five children in Nepal, say locals and experts," IRIN reports. "Women live hard lives from day one, born with no fanfare, contrasting starkly to the six-day celebration to mark the birth of a boy.

23 Sep 2011

Annual World Disasters Report focuses on hunger and malnutrition, highlights dichotomy between economic classes

This year's annual World Disasters Report, published by the International Federation of Red Cross and Red Crescent Societies on Thursday, focuses on hunger and malnutrition, but highlights a growing gap between economic classes, the Australian reports, noting "15 percent of the world's population is going hungry while a record 20 percent now suffer the effects of 'excess nutrition'" (Hodge, 9/23).

23 Sep 2011

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company's Marketing Authorisation Application for the once-daily single-tablet regimen, Eviplera.

23 Sep 2011

FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues

AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.

23 Sep 2011

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of promising hematology and cancer-related products, today reported operational and financial results for its 2011 fiscal year, ended June 30, 2011.

23 Sep 2011

Cutting foreign assistance funding might mean death for world's poor

In this opinion piece in The Hill's "Congress Blog," Rep. Barbara Lee D-Calif. writes that cutting "funding of vital programs that focus on global food security, health, climate adaptation, and disaster relief, which make up less than one percent of the U.S. federal budget, will not get us far in terms of plugging the budget gap but they could literally make the difference between life and death for many of the world's poor."

23 Sep 2011

Commercial interests confound fight against NCDs, some experts say

The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.

23 Sep 2011

IFRC releases 2011 World Disaster Report

The world's most vulnerable populations remain at significant risk to the effects of food shortages and malnutrition according to the 2011 World Disaster Report (WDR) released today by the International Federation of Red Cross and Red Crescent Societies.

23 Sep 2011

University of Kentucky receives Department of Defense grant for lung cancer study

The University of Kentucky's Dr. Susanne Arnold and colleagues were awarded a grant by the Department of Defense to study potential environmental reasons for the high lung cancer rates in Eastern Kentucky.

23 Sep 2011

AHA certifies walnuts as heart-healthy food

California Walnuts is proud to announce that the American Heart Association is now certifying walnuts as a heart-healthy food. The Heart-Check mark easily identifies foods that meet the nutritional standards set by the American Heart Association and provides consumers a quick and reliable way to identify heart-healthy foods.

23 Sep 2011

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

23 Sep 2011

PepsiCo, WFP, USAID announce partnership to increase chickpea production, address hunger in Ethiopia

PepsiCo on Wednesday announced a public-private partnership with the World Food Programme (WFP) and USAID to increase chickpea production in Ethiopia in order to secure access to the legume, which "plays an increasing role in its food products," the New York Times reports.

23 Sep 2011

Conference to explore how asset based approaches can enhance health among communities

Health researchers from the University of Hertfordshire will host an international conference at the British Library next week (26-27 September), which will explore how asset based approaches can enhance health among communities.

23 Sep 2011

Twenty aid agencies issue open letter urging international community to change approach in Somalia

Twenty aid agencies on Wednesday issued an open letter "urging the international community to change its approach to Somalia 'and enhance diplomatic engagement with the parties to the conflict, to ensure the unhindered delivery of humanitarian aid,'" particularly before the rainy season brings the threat of disease, IRIN reports.

23 Sep 2011

Food News and Research

Researchers discover 16 genes linked with breast cancer prognosis

The Journal of Pain publishes results from Butrans Transdermal System Phase 3 clinical study

RegeneRx completes RGN-259 Phase 2 trial on dry eye syndrome

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Gender discrimination a driving factor behind malnutrition in Nepal, experts say

Annual World Disasters Report focuses on hunger and malnutrition, highlights dichotomy between economic classes

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

Cutting foreign assistance funding might mean death for world's poor

Commercial interests confound fight against NCDs, some experts say

IFRC releases 2011 World Disaster Report

University of Kentucky receives Department of Defense grant for lung cancer study

AHA certifies walnuts as heart-healthy food

NIH honors Utah biochemist with Pioneer Award for dsRNA research

PepsiCo, WFP, USAID announce partnership to increase chickpea production, address hunger in Ethiopia

Conference to explore how asset based approaches can enhance health among communities

Twenty aid agencies issue open letter urging international community to change approach in Somalia

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News